<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: This study assesses the perioperative course and long-term survival of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD)-associated vs. <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> vs. SCRC) after elimination of known confounders </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Between 1991 and 2007, n = 3,299 patients underwent surgery for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> at our institution </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty-three IBD patients were identified and compared to 165 SCRC using a matched-pair analysis (1:5 scenario) </plain></SENT>
<SENT sid="3" pm="."><plain>As matching parameters were used: age, gender, Union Internationale Contre le <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> (UICC) stage, site of <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesion</z:e>, and date of surgery </plain></SENT>
<SENT sid="4" pm="."><plain>After univariate analysis of the perioperative course, a multivariate survival analysis (Cox) of <z:hpo ids='HP_0000001'>all</z:hpo> patients (n = 198) was performed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Significant differences were shown for preoperative symptoms (p = 0.022), transfusion rate (p = 0.01), ileostomy construction rate (p = 0.001), total complication rate (p = 0.042), and hospital stay (15 vs. 11 days, p &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Local <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence was three times higher in IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (p = 0.004), and the 5-year survival rate was lower (49 % vs. 67 %, p = 0.03) </plain></SENT>
<SENT sid="7" pm="."><plain>IBD, advanced UICC stage, and synchronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> were identified as independent prognostic factors </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: We demonstrate for the first time survival differences between IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and SCRC after elimination of five known confounders </plain></SENT>
<SENT sid="9" pm="."><plain>This might be caused by a difference in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biology resulting in a higher local recurrence rate in IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>